Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1(+) Myeloma Cells and Release Type-1 Cytokines

類似資料

• Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients
  著者:: Lum, Lawrence G., 等
  出版事項: (2020)
• Anti-CD3 × Anti-GD2 Bispecific Antibody Redirects T-Cell Cytolytic Activity to Neuroblastoma Targets
  著者:: Yankelevich, Maxim, 等
  出版事項: (2012)
• Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 × Anti-CMV Bispecific Antibody
  著者:: Lum, Lawrence G., 等
  出版事項: (2012)
• Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
  著者:: Vaishampayan, Ulka, 等
  出版事項: (2015)
• Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)
  著者:: Lum, Lawrence G, 等
  出版事項: (2015)